Literature DB >> 3464945

Tissue-specific expression and developmental regulation of the rat apolipoprotein B gene.

L A Demmer, M S Levin, J Elovson, M A Reuben, A J Lusis, J I Gordon.   

Abstract

Expression of the apolipoprotein B (apoB) gene was examined in a variety of fetal, neonatal, and adult rat tissues by probing RNA blots with a cloned rat apoB cDNA. Among 10 adult male tissues surveyed, small intestine had the highest concentration of apoB mRNA. Its abundance in liver and adrenal gland was 40% and 0.5%, respectively, of that in small bowel, while none was detected in colon, kidney, testes, spleen, lung, heart, or brain. ApoB mRNA is as abundant in 18-day fetal liver as at any subsequent period of hepatic development. In contrast, the concentration of apoB mRNA remains low in fetal intestine until the last (21st) day of gestation, when it increases sharply to levels that are several-fold higher than in the liver. ApoB mRNA levels in fetal membranes harvested during this late gestational period were 10 times greater than in fetal liver. Since the major lipoprotein species in 19-day fetal plasma is low density lipoprotein, these observations suggest that fetal liver, and particularly its functional homologue, the yolk sac, are the principal sites of fetal lipoprotein synthesis at this stage of development. A 20-fold increase in placental apoB mRNA concentrations during the last 48 hr of pregnancy (to a level that is 50% of that encountered in fetal membrane RNA) suggests a specific role for this organ in maternal-fetal lipid transport immediately prior to parturition. Pulse-labeling experiments using 21-day fetal tissue slices showed that the liver synthesizes both apoB-100 (B-PI) and apoB-48 (B-PIII) albeit in somewhat different ratios than the adult organ. Fetal intestine produces almost exclusively the smaller apoB species, while fetal membranes and placenta synthesize only the larger peptide. The postnatal pattern of apoB mRNA accumulation is similar in liver and intestine. Profound decreases were observed during the late suckling and weaning periods, followed by an increase to adult levels. These final concentrations were similar to those encountered at birth. Analysis of these developmental changes offers an opportunity to generate testable hypotheses about the factors that modulate apoB synthesis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3464945      PMCID: PMC386875          DOI: 10.1073/pnas.83.21.8102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Methylmercury as a reversible denaturing agent for agarose gel electrophoresis.

Authors:  J M Bailey; N Davidson
Journal:  Anal Biochem       Date:  1976-01       Impact factor: 3.365

2.  Morphogenesis of the small intestine during fetal development.

Authors:  J S Trier; P C Moxey
Journal:  Ciba Found Symp       Date:  1979 Jan 16-18

3.  Postnatal development of the small intestine of the rat. Changes in mucosal morphology at weaning.

Authors:  J J Herbst; P Sunshine
Journal:  Pediatr Res       Date:  1969-01       Impact factor: 3.756

4.  Synthesis of two forms of apolipoprotein B by cultured rat hepatocytes.

Authors:  J Bell-Quint; T Forte; P Graham
Journal:  Biochem Biophys Res Commun       Date:  1981-03-31       Impact factor: 3.575

5.  Human apolipoprotein B: chromosomal mapping and DNA polymorphisms of hepatic and intestinal species.

Authors:  M Mehrabian; R S Sparkes; T Mohandas; I J Klisak; V N Schumaker; C Heinzmann; S Zollman; Y H Ma; A J Lusis
Journal:  Somat Cell Mol Genet       Date:  1986-05

6.  Metabolic heterogeneity of apolipoprotein B in the rat.

Authors:  C E Sparks; J B Marsh
Journal:  J Lipid Res       Date:  1981-03       Impact factor: 5.922

7.  Lipids and lipoproteins in maternal and fetus plasma in the rat.

Authors:  J Argiles; E Herrera
Journal:  Biol Neonate       Date:  1981

8.  Variant forms of plasma apolipoprotein B. Hepatic and intestinal biosynthesis and heterogeneous metabolism in the rat.

Authors:  A L Wu; H G Windmueller
Journal:  J Biol Chem       Date:  1981-04-25       Impact factor: 5.157

9.  Apolipoprotein B is structurally and metabolically heterogeneous in the rat.

Authors:  J Elovson; Y O Huang; N Baker; R Kannan
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  30 in total

1.  Polycomb repressive complex 2 impedes intestinal cell terminal differentiation.

Authors:  Yannick D Benoit; Manon B Lepage; Taoufik Khalfaoui; Eric Tremblay; Nuria Basora; Julie C Carrier; Lorraine J Gudas; Jean-François Beaulieu
Journal:  J Cell Sci       Date:  2012-03-30       Impact factor: 5.285

2.  Hepatic very-low-density lipoprotein and apolipoprotein B production are increased following in vivo induction of betaine-homocysteine S-methyltransferase.

Authors:  Janet D Sparks; Heidi L Collins; Doru V Chirieac; Joanne Cianci; Jenny Jokinen; Mark P Sowden; Chad A Galloway; Charles E Sparks
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

3.  Synthesis, secretion and immunoelectron microscopic demonstration of apolipoprotein B-containing lipoprotein particles in the visceral rat yolk sac.

Authors:  H Franke; D Plonné; L Winkler; R Dargel
Journal:  Histochemistry       Date:  1992

4.  Functional characterization of APOBEC-1 complementation factor phosphorylation sites.

Authors:  David M Lehmann; Chad A Galloway; Celeste MacElrevey; Mark P Sowden; Joseph E Wedekind; Harold C Smith
Journal:  Biochim Biophys Acta       Date:  2006-12-08

5.  A genetic model for absent chylomicron formation: mice producing apolipoprotein B in the liver, but not in the intestine.

Authors:  S G Young; C M Cham; R E Pitas; B J Burri; A Connolly; L Flynn; A S Pappu; J S Wong; R L Hamilton; R V Farese
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

6.  Expression of apolipoprotein B mRNAs encoding higher- and lower-molecular weight isoproteins in rat liver and intestine.

Authors:  G E Tennyson; C A Sabatos; K Higuchi; N Meglin; H B Brewer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

7.  Knockout of the mouse apolipoprotein B gene results in embryonic lethality in homozygotes and protection against diet-induced hypercholesterolemia in heterozygotes.

Authors:  R V Farese; S L Ruland; L M Flynn; R P Stokowski; S G Young
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

8.  apo B gene knockout in mice results in embryonic lethality in homozygotes and neural tube defects, male infertility, and reduced HDL cholesterol ester and apo A-I transport rates in heterozygotes.

Authors:  L S Huang; E Voyiaziakis; D F Markenson; K A Sokol; T Hayek; J L Breslow
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

9.  Hepatocyte nuclear factor 1 and C/EBP are essential for the activity of the human apolipoprotein B gene second-intron enhancer.

Authors:  A R Brooks; B Levy-Wilson
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

10.  A novel functional role for apolipoprotein B in male infertility in heterozygous apolipoprotein B knockout mice.

Authors:  L S Huang; E Voyiaziakis; H L Chen; E M Rubin; J W Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.